Lessons learned from domestic and international human papillomavirus vaccination programs: a review - 01/11/17
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Since the development of the human papillomavirus vaccine, many countries have created implementation programs to bolster vaccination rates and protect their populations. Despite demonstrated efficacy with decreased human papillomavirus–related disease abroad, the vaccine's potential to prevent morbidity and mortality in the United States is not being met. The purpose of this review is to discuss strategies of both international and domestic vaccination programs, their impact on human papillomavirus–related diseases, the unique obstacles faced by the United States, and future directions for success.
Le texte complet de cet article est disponible en PDF.Key words : cervical cancer, health policy, human papillomavirus, vaccine policy
Plan
| Dr Huh is a consultant for TheVax, IncellDx, and Antiva. Drs Miller and Dilley have no conflict of interest to disclose. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?